Intracranial Hypertension (ICH)

Tags:
No items found.

Pathophysiology

Summary

Intracranial hypertension (ICH) manifests when pressure inside the skull is > 20 mmHg. ICH is often idiopathic, but can also occur in conditions such as hydrocephalus and cerebral edema. Cerebral edema shows loss of grey-white differentiation on imaging, and can either be intracellular—due to the movement of fluid from the interstitium into the cells—or interstitial—stemming from increased vessel permeability and subsequent fluid buildup outside brain cells. Two triggers for intracellular edema are hyponatremia and hypoxia. Hyponatremia decreases extracellular osmolality, drawing water into brain cells, while hypoxia damages brain cells, thus reducing Na+/K+ ATPase activity and an influx of water due to sodium accumulation. Interstitial edema leads to vasogenic intracranial hypertension, which can arise from factors like brain tumors (due to the formation of new leaky vessels), head trauma, and inflammation from conditions like meningitis or encephalitis.

Clinically, patients with ICH often report headaches, seizures, and vomiting, and may also exhibit altered mental statuses ranging from confusion to coma. Observing papilledema, diplopia (stretching of CN VI), and the Cushing’s reflex (hypertension, bradycardia, irregular respirations) can also serve as diagnostic indicators. Additionally, elevated intracranial pressure can precipitate gastric (Cushing) ulcers due to increased parasympathetic activity

Brain herniation is a severe complication of intracranial hypertension. Subfalcine herniation involves the cingulate gyrus herniating beneath the falx cerebri, which can compress the ACA and cause contralateral lower extremity motor and sensory deficits. Transtentorial hernias involve the herniation of the inferior occipital lobe and brainstem, which may shear branches of the basilar artery, resulting in Duret hemorrhages. Tonsillar hernias occur when the cerebellar tonsils move into the foramen magnum, which can compress the brainstem and is often fatal.

In uncal herniation, the medial temporal lobe segment herniates past the tentorium cerebelli, causing complications like CN III compression, causing mydriasis due to unopposed sympathetic tone, and a ‘down and out’ orientation due to the unopposed action of CN IV & VI. Uncal hernias can also compress the PCA, causing ipsilateral occipital lobe infarction, as well as contralateral homonymous hemianopsia (with macular sparing). Finally, compression of contralateral cerebral peduncle can cause ipsilateral hemiparesis.

Treatment strategies for intracranial hypertension aim to lower the intracranial pressure. Hyperventilation, which decreases PaCO2 and causes cerebral vasoconstriction, mannitol for osmotic diuresis, and ventriculostomy to drain excess CSF, are all employed in the treatment of ICH

Idiopathic intracranial hypertension (IIH) occurs from a mismatch in CSF production and resorption from an unknown origin. IIH most frequently occurs in obese women aged 15-45 and is not associated with ventricular enlargement. Certain drugs like OCPs, all-trans retinoic acid, tetracyclines, and isotretinoin also increase IIH risk. Symptomatology mirrors intracranial hypertension, with the addition of pulsatile tinnitus. Diagnosis involves lumbar puncture, which shows increased opening pressure. Potential sequelae of IIH includes permanent vision loss from untreated papilledema. Treatment involves acetazolamide and optic nerve sheath fenestration.

Lesson Outline

Don't stop here!

Get access to 155 more Pathophysiology lessons & 13 more medical school learning courses with one subscription!

Try 7 Days Free

FAQs

What is intracranial hypertension and how does it manifest clinically?

Intracranial hypertension (ICH) is a condition where the pressure inside the skull exceeds the normal range, specifically > 20 mmHg. Common symptoms include headache, seizures, vomiting, altered mental states such as confusion or coma, papilledema (swelling of the optic disc), and diplopia due to stretching of cranial nerve VI. Additionally, imaging may reveal effacement of sulci and a loss of grey-white differentiation indicative of cerebral edema.

How do hydrocephalus and cerebral edema contribute to intracranial hypertension?

Hydrocephalus, characterized by an accumulation of cerebrospinal fluid (CSF) in the ventricles, can lead to increased intracranial pressure. Cerebral edema, on the other hand, involves the swelling of brain tissue, a can be either intracellular edema, where fluid shifts into brain cells from the surrounding space, or interstitial edema, where fluid accumulates outside the brain cells due to increased vessel permeability. Both conditions can elevate intracranial pressure, resulting in intracranial hypertension.

What conditions are associated with vasogenic intracranial hypertension?

Vasogenic intracranial hypertension arises from increased vessel permeability, leading to fluid accumulation outside the brain cells. Common causes include brain tumors, which can form new, leaky blood vessels, and brain inflammation conditions like meningitis or encephalitis. Additionally, head trauma can also trigger vasogenic intracranial hypertension.

How does brain herniation relate to intracranial hypertension?

Brain herniation is a severe complication of intracranial hypertension. It involves the displacement of brain tissue from its usual position due to elevated intracranial pressure. Types of herniation include subfalcine (under the falx cerebri), transtentorial (past the tentorium cerebelli), and tonsillar (into the foramen magnum). These herniations can compress or shear vital brain structures, leading to significant damage or even death.

What treatment strategies are available for managing intracranial hypertension?

Several strategies can help manage intracranial hypertension. Hyperventilation can induce cerebral vasoconstriction by decreasing PaCO2, which reduces intracranial pressure. Mannitol, an osmotic diuretic, can decrease cerebral edema. Ventriculostomy allows for the drainage of CSF, further reducing pressure. In cases of idiopathic intracranial hypertension (IIH), acetazolamide can be prescribed to decrease CSF production, and optic nerve sheath fenestration can address papilledema.